Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II+ detection rates
Open Access
- 12 October 2015
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Causes & Control
- Vol. 27 (1), 15-25
- https://doi.org/10.1007/s10552-015-0678-1
Abstract
Within the last decade, SurePath and ThinPrep [both liquid-based cytology (LBC) tests] have replaced conventional cytology (CC) as primary test method in cervical cancer screening programs of multiple countries. The aim of our study was to examine the effect in the Dutch screening program.Keywords
This publication has 36 references indexed in Scilit:
- Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical CancerVaccine, 2012
- Cervical screening in England: The past, present, and futureCancer Cytopathology, 2012
- Prior knowledge of HPV status improves detection of CIN2+ by cytology screeningAmerican Journal of Obstetrics and Gynecology, 2011
- Comparison of ThinPrep and SurePath liquid‐based cytology and subsequent human papillomavirus DNA testing in ChinaCancer Cytopathology, 2011
- Cytologic Detection of Cervical Abnormalities Using Liquid-Based Compared With Conventional CytologyObstetrics & Gynecology, 2008
- Accuracy of reading liquid based cytology slides using the ThinPrep Imager compared with conventional cytology: prospective studyBMJ, 2007
- Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trialBMJ, 2007
- Results of the implementation of liquid-based cytology-SurePath in the Ontario screening programCancer, 2004
- Liquid-based cytology and conventional cervical smearsCancer, 2003
- Liquid-based cervical cytologyCancer, 2003